Residual Leukemia Levels During Second Remission in All - Theodore Zipf

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Cancer Institute (NCI)
Type: Exploratory/Developmental Grants (R21)
Project #: 3R21CA068235-02S1
Application #: 2822593
Study Section: Experimental Therapeutics Subcommittee 1 (ET)
Program Officer: Wu, Roy S

Project Start: 1996-07-01
Project End: 1999-06-30
Budget Start: 1997-07-01
Budget End: 1999-06-30
Support Year: 2
Fiscal Year: 1998
Total Cost
Indirect Cost

Institution

Name: University of Texas MD Anderson Cancer Center
Department: Pediatrics
Type: Other Domestic Higher Education
DUNS #: 001910777

City: Houston
State: TX
Country: United States
Zip Code: 77030

Related projects


NIH 1998 R21 CA	Residual Leukemia Levels During Second Remission in All Zipf, Theodore F. / University of Texas MD Anderson Cancer Center
NIH 1997 R21 CA	Residual Leukemia Levels During Second Remission in All Zipf, Theodore F. / University of Texas MD Anderson Cancer Center
NIH 1996 R21 CA	Residual Leukemia Levels During Second Remission in All Zipf, Theodore F. / University of Texas MD Anderson Cancer Center

Publications

Bunin, Nancy; Johnston, Dennis A; Roberts, W Mark et al. (2003) Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features. Br J Haematol 120:711-5

Comments

Be the first to comment on Theodore Zipf's grant